ALNYLAM PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Alnylam Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2011 to Q3 2024.
  • Alnylam Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $77.6M, a 3.28% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $77.6M +$2.46M +3.28% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $71.9M -$20.8M -22.4% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $67.5M +$4.01M +6.32% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $72M +$5.91M +8.94% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $75.2M +$13.8M +22.4% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $92.7M +$15.4M +20% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $63.5M -$6.37M -9.12% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $66.1M +$5.89M +9.78% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $61.4M +$26.1M +74.1% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $77.3M +$42.7M +123% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $69.8M +$27.1M +63.6% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $60.2M +$15.2M +33.7% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $35.3M -$2.67M -7.03% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $34.6M +$14.2M +69.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $42.7M +$23.6M +124% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $45M +$27M +149% Dec 31, 2020 10-K 2022-02-10
Q3 2020 $37.9M +$28.3M +294% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $20.4M +$10.7M +111% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $19M +$10M +111% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $18.1M +$9.45M +110% Dec 31, 2019 10-K 2021-02-11
Q3 2019 $9.63M -$6.43M -40% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $9.69M -$4.48M -31.6% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $9.04M +$3.82M +73.3% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $8.62M +$4.45M +107% Dec 31, 2018 10-K 2020-02-13
Q3 2018 $16.1M +$14.6M +992% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $14.2M +$12.7M +863% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $5.22M +$3.74M +255% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $4.17M +$2.61M +167% Dec 31, 2017 10-K 2019-02-14
Q3 2017 $1.47M -$90K -5.77% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $1.47M $0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.47M $0 0% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $1.56M +$91K +6.19% Dec 31, 2016 10-K 2018-02-15
Q3 2016 $1.56M Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $1.47M Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $1.47M Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $1.47M Dec 31, 2015 10-K 2017-02-15
Q4 2012 $101K -$738K -88% Dec 31, 2012 10-K 2013-02-19
Q4 2011 $839K Dec 31, 2011 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.